Overview
Hans-jurgen Reulen practices practicing medicine in Munich, Germany.
Their clinical expertise encompasses Glioma, Gliomatosis Cerebri, Glioblastoma, and Astrocytoma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hans-jurgen Reulen
Is Hans-jurgen Reulen a top-rated expert for Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Hans-jurgen Reulen is classified as an Experienced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hans-jurgen Reulen participate in research or clinical trials?
Yes. Hans-jurgen Reulen has published 8 articles and abstracts on conditions like Glioma. You can view a list of Hans-jurgen Reulen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaReulen isExperienced. Learn about Astrocytoma.
- Brain TumorReulen isExperienced. Learn about Brain Tumor.
- GlioblastomaReulen isExperienced. Learn about Glioblastoma.
- GliomaReulen isExperienced. Learn about Glioma.
- Gliomatosis CerebriReulen isExperienced. Learn about Gliomatosis Cerebri.